Resource Library

Browse articles

Perspectives, insights, and educational content from across the PharPoint team

Considerations for Choosing an Oncology CRO (Downloadable Workbook)

Considerations for Choosing an Oncology CRO (Downloadable Workbook)

Beginning the process of choosing a CRO for your oncology clinical trial? Download a free workbook to begin planning ...
Building Cost Confidence into CRO Selection and Study Governance

Building Cost Confidence into CRO Selection and Study Governance

What steps can you take during CRO selection and study execution to avoid being blindsided by your study budget? ...
Outsourcing to Multiple CROs: Improving Coordination Between Separate Clinical and Biometrics Providers

Outsourcing to Multiple CROs: Improving Coordination Between Separate Clinical and Biometrics Providers

Discover common pitfalls and mitigation strategies used when partnering with separate clinical operations and biometrics CROs ...
Navigating Complexity in Pulmonary Trials: Biomarker-Driven Approaches

Navigating Complexity in Pulmonary Trials: Biomarker-Driven Approaches

Exec. Director of Strategy Paul Johnson discusses biomarker-driven approaches for complex pulmonary trials ...
Navigating Complexity in Pulmonary Trials: Enrichment Strategies

Navigating Complexity in Pulmonary Trials: Enrichment Strategies

PharPoint's Exec. Dir. of Strategy Paul Johnson discusses the use of enrichment strategies in complex pulmonary trials ...
Navigating Complexity in Pulmonary Trials: Using Adaptive Trial Designs

Navigating Complexity in Pulmonary Trials: Using Adaptive Trial Designs

PharPoint's Exec. Dir. of Strategy Paul Johnson discusses the use of adaptive trial design for complex pulmonary trials ...
Preparing for ICH E6(R3): Understanding QbD, CtQ Factors, & Risk Management

Preparing for ICH E6(R3): Understanding QbD, CtQ Factors, & Risk Management

Explore the basics of quality by design, critical to quality factors, and what risks management means in the context of ...
Clinical Trial Activity in Japan and Taiwan (2015-2025): Trends and Phase Distribution

Clinical Trial Activity in Japan and Taiwan (2015-2025): Trends and Phase Distribution

A look at a decade of Phase 1-4 studies in Japan and Taiwan, from 2015 to 2025 according to ClinicalTrial.Gov ...
Preparing for ICH E6(R3): Understanding the 11 Core GCP Principles

Preparing for ICH E6(R3): Understanding the 11 Core GCP Principles

Explore the 11 GCP principles outlined in ICH E6(R3) ...

Trending resources

Considerations for Choosing an Oncology CRO (Downloadable Workbook)

Considerations for Choosing an Oncology CRO (Downloadable Workbook)

Beginning the process of choosing a CRO for your oncology clinical trial? Download a free workbook to begin planning ...
Clinical Trial Design: Ensuring Statistical Validity and Identifying Consulting Biostatisticians

Clinical Trial Design: Ensuring Statistical Validity and Identifying Consulting Biostatisticians

Why engage a biostatistician early in the study design process, and how do you identify the right consultant for your study? ...

Videos

PharPOV

Read perspectives from leaders across the PharPoint team in our PharPoint of View series

Fit Matters – CROs are Not All the Same | PharPOV Series

Fit Matters – CROs are Not All the Same | PharPOV Series

When it comes to CRO selection, fit matters, and not every vendor is the same. Hear from PharPoint co-founder Audra ...
In Clinical Research, AI Cannot Be A Substitute for Judgement | PharPOV Series

In Clinical Research, AI Cannot Be A Substitute for Judgement | PharPOV Series

Exec. Director of Strategy Development Paul Johnson talks about the use of AI in clinical research in this month's PharPOV ...
Assessing Quality Culture | PharPOV Series

Assessing Quality Culture | PharPOV Series

How mature is your organization’s quality culture? Hear from PharPoint's Director of Quality Assurance ...
Navigating Complexity in Pulmonary Trials | PharPOV Series

Navigating Complexity in Pulmonary Trials | PharPOV Series

Exec. Dir. Strategy Development Paul Johnson kicks off the first article in a series on pulmonary trial design ...
AI in Clinical Research | PharPOV Series

AI in Clinical Research | PharPOV Series

How can we make sure artificial intelligence (AI) is used ethically and responsibly in clinical research? Hear from PharPoint's VP ...
When Customer Service Isn't Enough | PharPOV Series

When Customer Service Isn’t Enough | PharPOV Series

PharPoint's Exec. Director of Client Experience explains where customer service can fall short, based on conversations after a recent move ...